News from bridge therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 23, 2019, 13:30 ET Bridge Therapeutics Announces the Addition of Edward J. Minskoff to Its Board of Directors

Bridge Therapeutics, an innovative startup pharmaceutical company developing a practical and safe therapy for chronic pain, is pleased to announce...


Nov 07, 2018, 17:15 ET Dr. Steven Passik Has Joined the Scientific Advisory Board of Bridge Therapeutics

Steve Passik Ph.D., Clinical Psychology, is a recognized leader and researcher in pain management and addiction. The intersection of pain and...


Nov 02, 2018, 20:38 ET Bridge Therapeutics Announces the Addition of Dr. Bob Rappaport to Its Scientific Advisory Board

Dr. Bob Rappaport, MD, has worked on advancing anesthesia, analgesia, and addiction drug-treatment research, discovery, and evaluation, in the...


Sep 21, 2018, 18:15 ET Dr. Bob Raffa Joins Bridge Therapeutics' Scientific Advisory Board Bring Decades of Research and Experience

Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member. "We are delighted...


Jul 11, 2018, 14:00 ET Pharma Startup, Bridge Therapeutics, to Participate in American Chronic Pain Association Roundtable With Agenda for Chronic Pain Drug Development Program

Executives with the innovative late development-stage pharmaceutical startup, Bridge Therapeutics, announced they will be introducing their chronic...


Mar 14, 2018, 07:00 ET Pharmaceutical Startup, Bridge Therapeutics, Announces Tim Peara Will Be Joining the Company as the Director of Finance

The innovative late development-stage pharmaceutical startup, Bridge Therapeutics® has announced Tim Peara will be joining its management team as the ...


Feb 21, 2018, 07:00 ET Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer

The innovative late development-stage pharmaceutical startup, Bridge Therapeutics®, has named David H. Bergstrom, Ph.D. as its new Chief Operating...


May 10, 2017, 08:00 ET Bridge Therapeutics to Present at BioTrinity 2017 Conference in London

Bridge Therapeutics, Inc., an innovative development-stage specialty pharmaceutical company, has announced that its CEO and Chief Scientific Officer...